Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5642 Journals
4484 Congresses
10100+ Unique Records

Rare Cancers and Therapy


Title Abbreviation
Rare Cancers Ther
ISSN
2195-6014
Electronic ISSN
2195-6022
Readership
Clinical Pharmacologists, Internists, Oncologists, Pharmacologists, Physicians, Toxicologists
Scope
Rare Cancers and Therapy is an international, peer-reviewed, rapid-publication journal dedicated to the publication of clinical and real-world research, reviews, brief reports, and case reports on the discovery, development, and use of therapies for rare tumors and hematological malignancies. Articles relating to diagnosis, instrumentation, pharmacoeconomics, outcomes, patient care, management, education, and quality of life are also encouraged. The journal also publishes enhanced features alongside articles for extra educational value.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Adis, part of Springer Nature
To see more details about Rare Cancers and Therapy, Subscribe Now!
Submission to Acceptance Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library